𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A study of the pharmacokinetics and pharmacodynamics of nifedipine in combination with atenolol

✍ Scribed by T. J. Fitzsimons; S. C. Norris; H. K. Adam; J. Ryan; J. McAinsh

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
469 KB
Volume
12
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

✦ Synopsis

This double-blind randomized, crossover study was undertaken to determine the pharmacokinetic properties of nifedipine retard and atenolol when given separately, as a free or a fixed combination, compared with placebo in 15 healthy male volunteers. There was no difference between the three atenolol formulations in time to maximum blood concentration or elimination half-life. The fixed combination showed significant differences in both maximum observed blood concentrations (+16 per cent) and total area under the curve (+16 per cent) compared to atenolol alone. Urinary recovery of unchanged drug from the fixed combination was also slightly increased but the difference was not statistically significant. Furthermore, statistical evaluation of the plasma pharmacokinetics of nifedipine retard and urinary recovery of nifedipine metabolite showed that all three formulations were indistinguishable. Thus, it is concluded that the fixed combination of nifedipine and atenolol is bioequivalent to the free combination and that the bioavailability of both drugs in the fixed combination is equivalent to that of the single entities.

πŸ“œ SIMILAR VOLUMES

Comparative pharmacokinetics and pharmac
Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects
✍ Jerzy WΓ³jcicki; Maria Jaroszynska; Marek DroΕΊdzik; Andrzej Pawlik; Barbara Gawro πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 1 views

## Abstract The lipophilic beta‐adrenoreceptor antagonist propranolol and hydrophilic atenolol have been studied to define their pharmacokinetic and pharmacodynamic characteristics in obese patients. A total of 43 subjects were allocated into three study groups: (1) healthy, lean, normolipaemic vol

Pharmacokinetics of mepindolol administe
Pharmacokinetics of mepindolol administered alone and in combination with hydrochlorothiazideβ€”a bioequivalence study
✍ W. Krause; Chr. Lennert πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 306 KB πŸ‘ 1 views

The bioavailability and pharmacokinetics of 10 mg of mepindolol sulphate and of 25 mg df hydrochlorothiazide were compared in a cross-over design in five healthy volunteers after the administration of either the single drugs (Corindolan@ and Esidrix@) or in combination (Tenesor@). Maximum concentra

Bioavailability in man of atenolol and c
Bioavailability in man of atenolol and chlorthalidone from a combination formulation
✍ James McAinsh; William Bastain; Jean Young; John D. Harry πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 428 KB πŸ‘ 2 views

## Abstract In this comparative bioavailability study in 12 healthy volunteers the blood level profiles and urinary recoveries of both atenolol and chlorthalidone were studied following the administration of the drug as a fixed combination (β€˜Tenoretic’), as a free combination, and individually, at

Bioavailability in man of atenolol and c
Bioavailability in man of atenolol and chlorthalidone from a combination formulation
✍ James McAinsh; Brian H. Holmes; Timothy J. Fitzsimons; Jean Young πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 438 KB πŸ‘ 2 views

In this comparative bioavailability study in 12 healthy volunteers the blood level profiles and urinary recoveries of both atenolol and chlorthalidone were studied following the administration of the drugs as a fixed combination ('Tenoret 50'). as a free combination, and individually, at doses of 50